TABLE 2.
Source | No. of samples tested | No. of samples positive by IMMULITE HBsAg assay with Elecsys HBsAg result that was:
|
No. of samples negative by IMMULITE HBsAg assay with Elecsys HBsAg result that was:
|
Agreement (%) | ||
---|---|---|---|---|---|---|
Positive | Negative | Positive | Negative | |||
Seroconversion panels | 363 | 168 | 0 | 19 | 176 | 94.8 |
Acute HBV infection | 12 | 12 | 0 | 0 | 0 | 100 |
Chronic HBV infection | 398 | 398 | 0 | 0 | 0 | 100 |
Blood donors | 1,733 | 0 | 0 | 0 | 1,733 | 100.0 |
Routine samples | 48 | 2 | 0 | 0 | 46 | 100.0 |
Hospitalized patientsa | 195 | 8 | 0 | 0 | 187 | 100 |
Potentially cross-reactive sera | 112 | 0 | 0 | 0 | 112 | 100.0 |
Total | 2,861 | 588 | 0 | 19 | 2,254 | 99.3 |
Eleven samples were not considered for final interpretation because not enough sample material was available for resolution of discrepant results.